scholarly journals Efficacy and Safety of Crizotinib among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients

PLoS ONE ◽  
2014 ◽  
Vol 9 (12) ◽  
pp. e114008 ◽  
Author(s):  
Yabing Cao ◽  
Guangli Xiao ◽  
Xibin Qiu ◽  
Sheng Ye ◽  
Tongyu Lin
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Advanced Stage ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Alk Positive

Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non–small cell lung cancer patients

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Po-Hsin Lee ◽  
Kun-Chieh Chen ◽  
Kuo-Hsuan Hsu ◽  
Yen-Hsiang Huang ◽  
Jeng-Sen Tseng ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Real World ◽  
Small Cell ◽  
Efficacy And Safety ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Alk Positive

scholarly journals Total Body Metabolic Tumor Response in ALK Positive Non-Small Cell Lung Cancer Patients Treated with ALK Inhibition

PLoS ONE ◽  
2016 ◽  
Vol 11 (5) ◽  
pp. e0149955 ◽  
Author(s):  
Gerald S. M. A. Kerner ◽  
Michel J. B. Koole ◽  
Alphons H. H. Bongaerts ◽  
Jan Pruim ◽  
Harry J. M. Groen ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Cell Lung Cancer ◽  
Tumor Response ◽  
Small Cell ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Alk Positive ◽  
Total Body
Sign in / Sign up

Export Citation Format

Share Document